Kirkland & Ellis advised Recipharm on the deal. Recipharm, a global contract development and manufacturing organisation (CDMO) and a portfolio company of EQT, executed the acquisition of...
Recipharm’s Acquisition of Vibalogics
Kriya Therapeutics’ $100 Million Series B Financing
Goodwin Procter LLP advised Kriya Therapeutics on the deal, while Kirkland & Ellis advised Patient Square Capital. Kriya Therapeutics announced the closing of a $100 Million Series...


























